Bristol-Myers Squibb
BMY
#189
Rank
NZ$183.77 B
Marketcap
NZ$90.27
Share price
0.38%
Change (1 day)
-6.55%
Change (1 year)

Bristol-Myers Squibb (BMY) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$167.71 Billion

According to Bristol-Myers Squibb's latest financial reports the company's total assets are NZ$167.71 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Bristol-Myers Squibb - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$164.19 B9.12%
2023-12-31NZ$150.47 B-1.33%
2022-12-31NZ$152.49 B-4.71%
2021-12-31NZ$160.04 B-2.54%
2020-12-31NZ$164.20 B-14.89%
2019-12-31NZ$192.94 B269.92%
2018-12-31NZ$52.15 B10.41%
2017-12-31NZ$47.24 B-2.92%
2016-12-31NZ$48.66 B4.9%
2015-12-31NZ$46.38 B7.69%
2014-12-31NZ$43.07 B-8.28%
2013-12-31NZ$46.96 B7.62%
2012-12-31NZ$43.63 B3.29%
2011-12-31NZ$42.24 B4.88%
2010-12-31NZ$40.28 B-5.65%
2009-12-31NZ$42.69 B-15.98%
2008-12-31NZ$50.81 B48.71%
2007-12-31NZ$34.16 B-5.88%
2006-12-31NZ$36.30 B-11.82%
2005-12-31NZ$41.16 B-3.48%
2004-12-31NZ$42.65 B1.01%
2003-12-31NZ$42.22 B-11.69%
2002-12-31NZ$47.81 B-28.61%
2001-12-31NZ$66.97 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
NZ$361.31 B 115.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$224.24 B 33.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$198.95 B 18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$185.71 B 10.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$263.67 B 57.21%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
NZ$198.12 B 18.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$333.76 B 99.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$231.77 B 38.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$156.03 B-6.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$50.55 B-69.85%๐Ÿ‡บ๐Ÿ‡ธ USA